- All sections
- C - Chemistrymetallurgy
- C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
- C12P 21/04 - Cyclic or bridged peptides or polypeptides, e.g. bacitracin
Patent holdings for IPC class C12P 21/04
Total number of patents in this class: 882
10-year publication summary
|
22
|
27
|
27
|
22
|
16
|
8
|
10
|
5
|
4
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4382 |
11 |
| Abbvie Inc. | 1820 |
11 |
| Regeneron Pharmaceuticals, Inc. | 4505 |
9 |
| Novartis AG | 10494 |
8 |
| The Regents of the University of California | 20355 |
8 |
| California Institute of Technology | 4006 |
8 |
| Ajinomoto Co., Inc. | 2302 |
8 |
| Bunge Oils, Inc. | 117 |
8 |
| Codexis, Inc. | 822 |
8 |
| The University of Tokyo | 4285 |
8 |
| Genentech, Inc. | 4040 |
7 |
| Novozymes A/S | 3344 |
7 |
| CJ Cheiljedang Corporation | 3525 |
7 |
| Gevo, Inc. | 274 |
7 |
| Allergan, Inc. | 2282 |
6 |
| President and Fellows of Harvard College | 6049 |
6 |
| Novartis Vaccines and Diagnostics, Inc. (a Delaware corporation) | 25 |
5 |
| Amgen Inc. | 4290 |
5 |
| Massachusetts Institute of Technology | 10181 |
5 |
| The General Hospital Corporation | 4793 |
5 |
| Other owners | 735 |